InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
T+90 hit rate
80%
T+90 mean return
+21.1%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Roivant Sciences Ltd.. Insider active across 2 companies, notably Immunovant, Inc.. Aggregated, 7 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €331.4m. History available since 6 October 2022. The latest transaction was filed on 13 January 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
16,845,010 shares@ US$20.0066.6% of flowCommon Stock, $0.0001 par value per shareSEC:0001140361-25-001188:0
Ideal exit: 10 Oct 2025 (T+270)
4,473,684 shares@ US$38.0032.9% of flowCommon Stock, $0.0001 par value per shareSEC:0001140361-23-046976:0
416,667 shares@ US$6.000.5% of flowCommon Stock, $0.0001 par value per shareSEC:0001140361-22-036652:0
Ideal exit: 3 Jul 2023 (T+270)
22,833,922 sharesCommon shares, without par valueSEC:0000950103-21-016172:0
22,833,922 sharesCommon shares, without par valueSEC:0000950103-21-016172
17,021,276 sharesCommon Stock, $0.0001 par value per shareSEC:0001104659-21-099083
17,021,276 sharesCommon Stock, $0.0001 par value per shareSEC:0001104659-21-099083:0
7 of 7 declarations
About Roivant Sciences Ltd.
Roivant Sciences Ltd. has 7 filings in total. Among the recent filings held here, they span the period from 2021-08-02 to 2025-01-15, with EUR 331415659 of purchases and EUR 0 of sales. The filings concern Immunovant, Inc., where the company is listed as Director, and Arbutus Biopharma Corp.
